31698056|t|A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-beta toxicity.
31698056|a|The microtubule-associated protein Tau is strongly implicated in Alzheimer's disease (AD) and aggregates into neurofibrillary tangles in AD. Genetic reduction of Tau is protective in several animal models of AD and cell culture models of amyloid-beta (Abeta) toxicity, making it an exciting therapeutic target for treating AD. A variety of evidence indicates that Tau's interactions with Fyn kinase and other SH3 domain-containing proteins, which bind to PxxP motifs in Tau's proline-rich domain, may contribute to AD deficits and Abeta toxicity. Thus, we sought to determine if inhibiting Tau-SH3 interactions ameliorates Abeta toxicity. We developed a peptide inhibitor of Tau-SH3 interactions and a proximity ligation assay (PLA)-based target engagement assay. Then, we used membrane trafficking and neurite degeneration assays to determine if inhibiting Tau-SH3 interactions ameliorated Abeta oligomer (Abetao)-induced toxicity in primary hippocampal neurons from rats. We verified that Tau reduction ameliorated Abetao toxicity in neurons. Using PLA, we identified a peptide inhibitor that reduced Tau-SH3 interactions in HEK-293 cells and primary neurons. This peptide reduced Tau phosphorylation by Fyn without affecting Fyn's kinase activity state. In primary neurons, endogenous Tau-Fyn interaction was present primarily in neurites and was reduced by the peptide inhibitor, from which we inferred target engagement. Reducing Tau-SH3 interactions in neurons ameliorated Abetao toxicity by multiple outcome measures, namely Abetao-induced membrane trafficking abnormalities and neurite degeneration. Our results indicate that Tau-SH3 interactions are critical for Abetao toxicity and that inhibiting them is a promising therapeutic target for AD.
31698056	23	26	Tau	Gene	4137
31698056	56	77	amyloid-beta toxicity	Disease	MESH:D017772
31698056	114	117	Tau	Gene	4137
31698056	144	163	Alzheimer's disease	Disease	MESH:D000544
31698056	165	167	AD	Disease	MESH:D000544
31698056	189	212	neurofibrillary tangles	Disease	MESH:D055956
31698056	216	218	AD	Disease	MESH:D000544
31698056	241	244	Tau	Gene	4137
31698056	287	289	AD	Disease	MESH:D000544
31698056	331	336	Abeta	Gene	54226
31698056	338	346	toxicity	Disease	MESH:D064420
31698056	402	404	AD	Disease	MESH:D000544
31698056	443	446	Tau	Gene	4137
31698056	549	552	Tau	Gene	4137
31698056	594	596	AD	Disease	MESH:D000544
31698056	669	672	Tau	Gene	4137
31698056	754	757	Tau	Gene	4137
31698056	882	902	neurite degeneration	Disease	MESH:D009410
31698056	937	940	Tau	Gene	4137
31698056	986	992	Abetao	Gene	100301568
31698056	1002	1010	toxicity	Disease	MESH:D064420
31698056	1047	1051	rats	Species	10116
31698056	1070	1073	Tau	Gene	4137
31698056	1096	1102	Abetao	Gene	100301568
31698056	1103	1111	toxicity	Disease	MESH:D064420
31698056	1182	1185	Tau	Gene	4137
31698056	1206	1213	HEK-293	CellLine	CVCL:0045
31698056	1262	1265	Tau	Gene	4137
31698056	1285	1288	Fyn	Gene	2534
31698056	1307	1310	Fyn	Gene	2534
31698056	1367	1370	Tau	Gene	4137
31698056	1371	1374	Fyn	Gene	2534
31698056	1514	1517	Tau	Gene	4137
31698056	1558	1564	Abetao	Gene	100301568
31698056	1565	1573	toxicity	Disease	MESH:D064420
31698056	1611	1617	Abetao	Gene	100301568
31698056	1665	1685	neurite degeneration	Disease	MESH:D009410
31698056	1713	1716	Tau	Gene	4137
31698056	1751	1757	Abetao	Gene	100301568
31698056	1758	1766	toxicity	Disease	MESH:D064420
31698056	1830	1832	AD	Disease	MESH:D000544
31698056	Association	2534	4137
31698056	Association	MESH:D009410	4137
31698056	Positive_Correlation	MESH:D064420	100301568
31698056	Negative_Correlation	100301568	4137
31698056	Association	MESH:D000544	4137
31698056	Association	MESH:D064420	4137
31698056	Association	MESH:D055956	4137
31698056	Association	4137	54226

